149 related articles for article (PubMed ID: 21154119)
1. Gene therapy for HCV/HBV-induced hepatocellular carcinoma.
Smerdou C; Menne S; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1368-77. PubMed ID: 21154119
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of hepatocellular carcinoma.
Omata M; Yoshida H
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S111-4. PubMed ID: 14762850
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
7. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
9. Molecular therapy and prevention of hepatocellular carcinoma.
Blum HE
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy strategies for hepatocellular carcinoma.
Hwang LH
J Biomed Sci; 2006 Jul; 13(4):453-68. PubMed ID: 16633742
[TBL] [Abstract][Full Text] [Related]
11. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
12. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
13. The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.
Zemel R; Issachar A; Tur-Kaspa R
Clin Liver Dis; 2011 May; 15(2):261-79, vii-x. PubMed ID: 21689612
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
16. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
18. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.
He D; Liu ZP; Honda M; Kaneko S; Chen L
J Mol Cell Biol; 2012 Jun; 4(3):140-52. PubMed ID: 22467683
[TBL] [Abstract][Full Text] [Related]
19. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
[TBL] [Abstract][Full Text] [Related]
20. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
Feitelson MA
Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
